CurrentEndo
Get Weekly

Topic · page 10 of 64

Obesity

Overweight and obesity in adults and children: weight-lowering drugs, lifestyle, metabolic and bariatric surgery against other treatment, weight-related disease, lipodystrophy

Briefs 361–400 of 2,541 placed here, newest publication first

Briefs in Obesity

Newest publication first

  1. Obesity (Silver Spring)

    Cardiovascular Disease and Obesity Medications in Older Women by Obesity‐Related Cancers Status: SEER ‐Medicare 2007–2015

    Cohort study

  2. Pediatr Obes

    Continuous Glucose Monitoring Metrics Are Associated With Metabolic Dysfunction–Associated Steatotic Liver Disease and Not Dysglycaemia in Adolescents With Obesity—A Pilot Study

    Research article

  3. JAMA Intern Med

    Heterogeneity of Treatment Effects of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss in Adults: A Systematic Review and Meta-Analysis

    Meta-analysis

  4. JAMA Netw Open

    Optimal Dietary Patterns for Lower Weight Gain and Risk of Obesity Surrounding Menopause

    Cohort study

  5. Int J Obes (Lond)

    Association of childhood-to-adulthood body size trajectories with cardiovascular risk and all cause mortality

    Cohort study

  6. Nat Med

    Data-driven prioritization of high-risk individuals for weight loss interventions

    Diagnostic or prognostic study

  7. Cardiovasc Diabetol

    Obesity and insulin resistance trigger the early onset of adolescent-like sexually dimorphic metabotypes in middle childhood

    Cross-sectional study

  8. Diabetes Obes Metab

    Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity

    Research article

  9. Diabetes Metab

    Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin

    Cross-sectional study

  10. Obesity (Silver Spring)

    Gene–Environment Interplay Between Residential Walkability and BMI : A Finnish Twin Study

    Research article

  11. Diabetes Obes Metab

    Obesity in Late Adolescence and Healthcare Costs in Young to Mid‐Adulthood

    Cohort study

  12. Diabetes Obes Metab

    Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials

    Meta-analysis

  13. Diabetes Obes Metab

    Six‐Month Real‐World Effectiveness, Persistence and Safety of Low‐to‐Moderate Dose Tirzepatide in Adults With Obesity: A Multicentre Observational Study

    Cohort study

  14. Diabetes Obes Metab

    Semaglutide 2.4 mg Cardiometabolic Long‐Term Effects in Patients With Obesity or Overweight in a Real‐World Setting: A Retrospective Cohort Study in the United States ( SMILE )

    Cohort study

  15. Obesity (Silver Spring)

    Parental Communication With Children Around Obesity Management Medications, Weight Loss, and Health Behavior Change

    Cross-sectional study

  16. Int J Obes (Lond)

    GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic review and meta-analysis

    Meta-analysis

  17. Int J Obes (Lond)

    Bariatric surgery and subsequent weight loss lead to a reversal of peripheral blood monocytosis in obesity

    Cohort study

  18. Diabetes Obes Metab

    A Randomized Effectiveness Trial of a Dissonance‐Based Dual Obesity and Eating Disorder Prevention Program

    Randomized controlled trial

  19. Diabetes Obes Metab

    Efficacy, Safety and PK of Once‐Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug Development Approach

    Research article

  20. Diabetes Obes Metab

    Integrated miRNA – mRNA Analysis Reveals Obesity‐Driven Regulatory Networks in Human Visceral Adipose Tissue With and Without Type 2 Diabetes

    Cross-sectional study

  21. Diabetes Care

    Life Course Cumulative BMI Burden From Childhood to Adulthood and Risk of Metabolic Multimorbidity: A 36-Year Prospective Cohort Study

    Cohort study

  22. Diabetes Obes Metab

    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials

    Randomized controlled trial

  23. Diabetes Care

    Long-term Air Pollution and Overall and Regional Body Composition in Older Adults With Overweight or Obesity and Metabolic Syndrome

    Cohort study

  24. Int J Obes (Lond)

    Circulating lipid subfractions and the risk of longitudinal adiposity progression: findings from the China Kadoorie Biobank

    Cohort study

  25. Pediatr Obes

    Regional Variations in Overweight and Obesity Among School‐Aged Adolescents: Evidence From the Cross‐Sectional Health Behaviour in School‐Aged Children Study in 26 European Union Countries

    Cross-sectional study

  26. Pediatr Obes

    Relative Skeletal Muscle Mass Is Associated With Hepatic Steatosis in Adolescents With Overweight and Obesity

    Secondary analysis

  27. Obesity (Silver Spring)

    Association of Weight Status and Quality of Life Through Childhood and Adolescence: Australian Longitudinal Cohort Analysis

    Cohort study

  28. Diabetes Obes Metab

    Higher Body Mass Index Is a Causal Risk Factor for Skin Infections: A Mendelian Randomisation Study Using UK Biobank and FinnGen

    Research article

  29. Diabetes Obes Metab

    A Phase 1, Randomised, Double‐Blind, Placebo‐Controlled Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN069 (a Dual GLP ‐ 1R Agonist and GIPR Antagonist) in Male Adults With Overweight or Obesity

    Randomized controlled trial

  30. Obesity (Silver Spring)

    Prevalence of Preclinical and Clinical Obesity Among US Children and Adolescents Aged 5 to 18 Years: NHANES 2017–2023

    Cross-sectional study

  31. Int J Obes (Lond)

    Metabolically healthy obesity is independently associated with 20-year incidence of cardiovascular disease: findings from the ATTICA cohort study (2002–2022)

    Cohort study

  32. Lancet Diabetes Endocrinol

    Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial

    Randomized controlled trial

  33. Ann Intern Med

    Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition : A Systematic Review

    Meta-analysis

  34. Diabetes Obes Metab

    Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight

    Research article

  35. Diabetes Metab

    The association between primary bile acids and metabolically unhealthy obesity

    Cross-sectional study

  36. Diabetes Obes Metab

    Cardiometabolic Profiles of Oral and Subcutaneous Glucagon‐Like Peptide‐1 Receptor Mono‐Agonists in Adults With Overweight or Obesity: A Systematic Review and Network Meta‐Analysis

    Meta-analysis

  37. Int J Obes (Lond)

    Association of cord blood mitochondrial DNA heteroplasmy and copy number with childhood overweight or obesity

    Cohort study

  38. Int J Obes (Lond)

    The association of prenatal adiposity characteristics with early childhood overweight and obesity: findings from a large and diverse mother–child cohort

    Cohort study

  39. Diabetes Obes Metab

    Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease and Type 2 Diabetes

    Cohort study

  40. Obesity (Silver Spring)

    Determinants of Parents' and Adolescents' Motivation Before Pediatric Weight Management—Data From the STARKIDS Cohort

    Cross-sectional study

All 2,541 Briefs in ExploreShowing Briefs 361–400 of 2,541, newest first